Showing results (361-370 of 387) with videos related to
Sort By:
Pageof 39
Circulation|May 21, 1998
Extended mortality benefit of early postinfarction reperfusion. GUSTO-I Angiographic Investigators. Global Utilization of Streptokinase and Tissue Plasminogen Activator for Occluded Coronary Arteries TrialA M Ross, K S Coyne, E Moreyra, et al.Immunogenetics|January 1, 1985
Interaction between des-Tyr1-gamma-endorphin and HLA class I molecules: serological detection of an HLA-A2 subtypeF H Claas, J J van der Poel, R Castelli-Visser, et al.JAMA|January 27, 2000
Association between minor elevations of creatine kinase-MB level and mortality in patients with acute coronary syndromes without ST-segment elevation. PURSUIT Steering Committee. Platelet Glycoprotein IIb/IIIa in Unstable Angina: Receptor Suppression Using Integrilin TherapyJ H Alexander, R A Sparapani, K W Mahaffey, et al.Circulation|October 7, 1998
Prediction of 30-day mortality among patients with thrombolysis-related intracranial hemorrhageM A Sloan, C A Sila, K W Mahaffey, et al.Circulation|February 23, 2000
Early percutaneous coronary intervention, platelet inhibition with eptifibatide, and clinical outcomes in patients with acute coronary syndromes. PURSUIT InvestigatorsN S Kleiman, A M Lincoff, G C Flaker, et al.Circulation|January 26, 1999
Effects of stroke on medical resource use and costs in acute myocardial infarction. GUSTO I Investigators. Global Utilization of Streptokinase and Tissue Plasminogen Activator for Occluded Coronary Arteries StudyC Y Tung, C B Granger, M A Sloan, et al.British Journal of Sports Medicine|September 8, 2009
Risk factors for exercise-related acute cardiac events. A case-control studyW M van Teeffelen, M F de Beus, A Mosterd, et al.European Heart Journal|July 24, 2001
Bisoprolol reduces cardiac death and myocardial infarction in high-risk patients as long as 2 years after successful major vascular surgeryD Poldermans, E Boersma, J J Bax, et al.Circulation|September 7, 2000
Clinical and therapeutic profile of patients presenting with acute coronary syndromes who do not have significant coronary artery disease.The Platelet Glycoprotein IIb/IIIa in Unstable Angina: Receptor Suppression Using Integrilin Therapy (PURSUIT) Trial InvestigatorsM T Roe, R A Harrington, D M Prosper, et al.Current Medical Research and Opinion|March 11, 2008
A double-blind, randomized study evaluating losartan potassium monotherapy or in combination with hydrochlorothiazide versus placebo in obese patients with hypertensionS Oparil, N Abate, E Chen, et al.Pageof 39